Skip to main content
. 2022 Nov 15;13(11):2115. doi: 10.3390/genes13112115

Table 5.

Comparison of MS between the four subgroups: case group with alternate allele, case group with wild-type allele, control group with alternate allele, and control group with wild-type allele.

Case Group Control Group
Gene SNV MS Alternate Allele MS Wild-Type MS Alternate Allele MS Wild-Type p
AXIN1 rs370681 71.98 (SD: ±35.66) 75. 64 (SD: ±37.19) 98.19 (SD: ±49.09) 94.81 (SD: ±28.77) 0.651
rs12921862 74.95 (SD: ±35.26) 66.58 (SD: ±21.52) 70.26 (SD: ±27.03) 101 (SD: ±41.64) 0.093
rs1805105 74.09 (SD: ±34.78) 73.47 (SD: ±38.46) 99.015 (SD: ±44.78) 92.1 (SD: ±29.98) 0.574
TBX20 rs4720169 5.23 (SD: ±7.99) 2.37 (SD: ±0.43) 10.46 (SD: ±22.41) 12.10 (SD: ±21.71) 0.354
TBX1 rs41260844 5.97 (SD: ±4.1) 3.88 (SD: ±5.97) 4.84 (SD: ±7.2) 6.2 (SD: ±12.53) 0.064
MTHFR rs1801133 4.85 (SD: ±6.63) 4.34 (SD: ±4.90) 37.34 (SD: ±85.9) 3.245 (SD: ±8.8) 0.004
rs1801131 4.48 (SD: ±5.88) 4.46 (SD: ±2.68) 10.89 (SD: ±43.18) 4.52 (SD: ±4.76) 0.007

MS—methylation status. Statistically significant difference: p < 0.0471 by Bonferroni inequalities.